Ezetimibe and Emtricitabine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ezetimibe (ezetimibe) and Emtricitabine (emtricitabine). Common drug interactions include cd4 lymphocytes decreased among females and blood creatine phosphokinase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Ezetimibe and Emtricitabine. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Emtricitabine?

Emtricitabine has active ingredients of emtricitabine. eHealthMe is studying from 6,391 Emtricitabine users. Check the latest studies of Emtricitabine.

On Aug, 11, 2026

20 people who take Ezetimibe and Emtricitabine together, and have interactions are studied.

Ezetimibe and Emtricitabine drug interactions.

What are the common drug interactions of Ezetimibe and Emtricitabine, by gender? *:

female:

Cd4 lymphocytes decreased

male:

Blood creatine phosphokinase increased
Dyslipidaemia (abnormal amount of lipids)
Acute myocardial infarction (acute heart attack)
Cerebral infarction (less blood supply to brain resulting tissue damage)
Myalgia (muscle pain)
Myoglobinaemia (myoglobin in blood)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Carotid artery occlusion (artery blockage)
Cerebrovascular stenosis (narrowing of brain blood vessels)
Vertebral artery occlusion (vertebral artery blockage)

What are the common drug interactions of Ezetimibe and Emtricitabine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Acute myocardial infarction (acute heart attack)
Blood creatine phosphokinase increased
Cerebral infarction (less blood supply to brain resulting tissue damage)
Dyslipidaemia (abnormal amount of lipids)
Myalgia (muscle pain)
Myoglobinaemia (myoglobin in blood)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Cerebrovascular disorder (disease of brain)
Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
Carotid artery occlusion (artery blockage)

50-59:

Renal failure acute (rapid kidney dysfunction)
Sepsis (a severe blood infection that can lead to organ failure and death)
Vertebral artery occlusion (vertebral artery blockage)
Blood creatine phosphokinase increased
Carotid artery occlusion (artery blockage)
Cellulitis (infection under the skin)
Cerebrovascular stenosis (narrowing of brain blood vessels)
Dehydration (dryness resulting from the removal of water)
Dyslipidaemia (abnormal amount of lipids)
Pneumonia

60+:

Chronic kidney disease
Renal impairment (severely reduced kidney function)

What are the existing conditions these people have? *

Hiv Infection: 12 people, 60.00%
Type 2 Diabetes: 4 people, 20.00%
Asthma: 4 people, 20.00%
Insomnia (sleeplessness): 4 people, 20.00%
Dyslipidaemia (abnormal amount of lipids): 4 people, 20.00%
Genital Herpes (herpes infection of genital): 3 people, 15.00%
Anaemia (lack of blood): 3 people, 15.00%
Candidiasis (candidiasis or thrush is a fungal infection): 3 people, 15.00%
Fungal Nail Infection: 3 people, 15.00%
Allergic Rhinitis: 3 people, 15.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and Emtricitabine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously